Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-09 Option Award |
2023-08-09 4:30 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-05 4:00 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-09 3:07 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
150,000 | $0 | 151,445 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 10:23 am |
N/A 2032-11-04 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:25 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
40,000 | $0 | 40,000 (Direct) |
View |